-
Tuesday's verdict comes as CVS, Walgreens and Walmart face thousands of lawsuits filed by communities across the U.S. The companies say they did nothing wrong dispensing huge quantities of opioids.
-
The Biden administration scrambles to respond as new data from the Centers for Disease Control and Prevention show overdose deaths surged to more than 100,000 fatalities.
-
A West Virginia pharmacist wanted to help those hit by the opioid crisis. But a few years after he began providing medications to treat addiction, drug enforcement raided his pharmacy.
-
Judge Colleen McMahon was expected to halt work on the controversial settlement that would give immunity from opioid lawsuits to the Sackler family. Instead she allowed work on the plan to go ahead.
-
People who were addicted to OxyContin or lost loved ones who were addicted to the drug expect very little in compensation from the multibillion-dollar Purdue Pharma bankruptcy settlement.
-
The country is re-thinking how scarce resources are allocated to police budgets, mental health and addiction workers, and other social services. In Vermont, the Department of Public Safety is hiring its first-ever director of mental health programs.
-
Black communities face a growing share of overdoses, but addiction treatment resources and attention are still focused on white communities.
-
The decision by a federal bankruptcy judge grants members of the family who own Purdue Pharma, maker of OxyContin, sweeping protection from any liability for the opioid crisis.
-
Judge Robert Drain signaled he will approve the landmark bankruptcy for Purdue Pharma, the maker of OxyContin. But he called for new limits to legal protections for members of the Sackler family.
-
In the Purdue Pharma bankruptcy trial now underway, scrutiny has focused on the Sacklers' demand for immunity from opioid lawsuits that would extend to a vast network of individuals and businesses.